Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on March 10, 2022. The filing serves to announce the Company's financial results for the period ended December 31, 2021, and provides an update on recent corporate events. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing indicates that material information regarding the period ended December 31, 2021, and recent corporate events is contained within the furnished exhibits. No specific comparative data or material changes are quantified in the body of this 8-K document.
Guidance, Outlook, and Risks
Management commentary, guidance, and outlook are referenced as being available in the press release and letter to stockholders (Exhibits 99.1 and 99.2). The filing explicitly states that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and does not constitute an admission of material information under Regulation FD. The Company assumes no obligation to update the information in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue and earnings figures for the year ended December 31, 2021.
- Review Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and strategic updates.
- Verify the status of the 8.625% Senior Notes due 2026 (HROWL) as listed in the securities registered section.
- Confirm that the information in the exhibits has not been superseded by subsequent filings, as the Company disclaims an obligation to update this specific 8-K content.